Influence of COVID-19 on the notification of drug-resistant pulmonary tuberculosis cases (2023)
Fonte: BMC Infectious Diseases. Unidades: EERP, FMRP
Assuntos: COVID-19, TUBERCULOSE, MEDICAMENTO, EPIDEMIOLOGIA
ABNT
ORFÃO, Nathalia Halax et al. Influence of COVID-19 on the notification of drug-resistant pulmonary tuberculosis cases. BMC Infectious Diseases, v. 23, 2023Tradução . . Disponível em: https://doi.org/10.1186/s12879-023-08463-x. Acesso em: 05 nov. 2024.APA
Orfão, N. H., Andrade, R. L. de P., Ruffino Netto, A., Silva, L. W. F. da, Villa, T. C. S., Seifert, M. L., et al. (2023). Influence of COVID-19 on the notification of drug-resistant pulmonary tuberculosis cases. BMC Infectious Diseases, 23. doi:10.1186/s12879-023-08463-xNLM
Orfão NH, Andrade RL de P, Ruffino Netto A, Silva LWF da, Villa TCS, Seifert ML, Zilly A, Arcoverde MAM, Hoare I, Izurieta R, Silva-Sobrinho RA da. Influence of COVID-19 on the notification of drug-resistant pulmonary tuberculosis cases [Internet]. BMC Infectious Diseases. 2023 ; 23[citado 2024 nov. 05 ] Available from: https://doi.org/10.1186/s12879-023-08463-xVancouver
Orfão NH, Andrade RL de P, Ruffino Netto A, Silva LWF da, Villa TCS, Seifert ML, Zilly A, Arcoverde MAM, Hoare I, Izurieta R, Silva-Sobrinho RA da. Influence of COVID-19 on the notification of drug-resistant pulmonary tuberculosis cases [Internet]. BMC Infectious Diseases. 2023 ; 23[citado 2024 nov. 05 ] Available from: https://doi.org/10.1186/s12879-023-08463-x